Bottneuro AG | Leading provider of diagnosis and treatment of AD
We envision Alzheimer's disease to become manageable and allow patients to regain an independent life. Bottneuro aims to become the leading provider of diagnosis and treatment of Alzheimer's disease using digital biomarkers, brain imaging and neuromodulation technologies. Our Miamind Diagnostics is an advanced and customized 3D-printed device that offers intuitive and convenient detection and monitoring of neurological diseases. It captures and analyzes brainwave patterns in the comfort of your own home, providing valuable insights for early intervention and personalized management of these conditions. Miamind Therapeutics is our personalized device designed for non-invasive, multifocal electrical stimulation of specific brain regions at predefined frequencies.
This company is:
Keywords
Industries
Where is Bottneuro located?
The company Bottneuro is located in Basel, Basel-City, Switzerland. It's worth noting that the company may has more corporate locations
How many employees does Bottneuro approximately have?
As of the latest available information Bottneuro has around 11-50 employees worldwide.
When was Bottneuro founded?
Bottneuro was founded in 2021
In which industries does Bottneuro mainly work?
The company Bottneuro has it's main focus in the industries of Health Care
What is the current company status of Bottneuro?
Based on the founding year and the amount of employees the company Bottneuro seems to be a Startup at the current state. Note that over time that status can change
ViewMind Inc.
United States
11-50 Employees
Multinostics Inc.
United States
1-10 Employees
2021
MindAffect
Netherlands
1-10 Employees
2017
Noisis Inc.
Canada
1-10 Employees
2017
Oscillo Biosciences
United States
1-10 Employees
1998
Kurve Technology
United States
11-50 Employees
2001
NeuraLight
Israel
11-50 Employees
2021
MIND ALGN
United States
11-50 Employees
2019
Topics which have been searched by others and may be interesting for you:
